Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | F12 | P00748 | 1/20 | 0.37 |
| ▸ | F7 | P08709 | 1/20 | 0.37 |
| ▸ | F3 | P13726 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.34 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | C1S | P09871 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22744840 | 0.79 | F2 (0.42) | F2F10F12F7F3 | |
| SCHEMBL8213110 | 0.78 | F2 (0.46) | F2F10F12F7F3 | |
| SCHEMBL15990065 | 0.78 | BLM (0.41) | F2F10F12F7F3 | |
| SCHEMBL17117437 | 0.77 | LMNA (0.45) | F2F10F12F7F3 | |
| SCHEMBL17400227 | 0.75 | F2 (0.39) | F2F10F12F7F3 | |
| SCHEMBL22606319 | 0.75 | F2 (0.50) | F2F10F12F7F3 | |
| SCHEMBL2669047 | 0.75 | F2 (0.39) | F2F10F12F7F3 | |
| SCHEMBL21746859 | 0.74 | CES2 (0.33) | KMT2ACES2CES1LMNAL3MBTL1 | |
| SCHEMBL23134314 | 0.72 | ALDH1A1 (0.42) | F2F10F12F7F3 | |
| SCHEMBL280430 | 0.71 | F2 (0.48) | F2F10F12F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2141152-B1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2021-05-05 | — | — | EP | disclosed |
| US-20200283463-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-09-10 | — | — | US | disclosed |
| US-10693076-B2 | Condensed-cyclic compound and organic light-emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-23 | — | — | US | disclosed |
| US-20200055886-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
| US-10461262-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-29 | — | — | US | disclosed |
| US-20180076392-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180076392-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | MCM7, CCNB2, CCNE2 | F2 412/4885F10 1871/4885F12 1292/4885 |
| US-20200283463-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, AP1M1, FOXM1 | F2 129/4885F10 600/4885F12 1654/4885 |
| US-10461262-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNA1 | F2 461/4885F10 1359/4885F12 2226/4885 |
| US-10693076-B2 | Condensed-cyclic compound and organic light-emitting device comprising the same | MCM7, CCNB2, CCNE2 | F2 412/4885F10 1871/4885F12 1292/4885 |
| US-20200055886-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ORMDL3, ORC3, OR10J3 | F2 2549/4885F10 3202/4885F12 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.